New review confirms maternal RSV vaccination significantly protects infants with reassuring safety profile

A systematic review indicates that vaccinating pregnant women with Pfizer’s Abrysvo can cut severe RSV illness in infants by up to 84%, offering promising safety data and supporting current immunisation guidelines amidst calls for broader global research. A new systematic…















